The Greek study in the effects of colchicine in COvid-19 complications prevention (GRECCO-19 study): Rationale and study design
- PMID: 32251729
- PMCID: PMC7194546
- DOI: 10.1016/j.hjc.2020.03.002
The Greek study in the effects of colchicine in COvid-19 complications prevention (GRECCO-19 study): Rationale and study design
Abstract
Objective: Colchicine has been utilized safely in a variety of cardiovascular clinical conditions. Among its potential mechanisms of action is the non-selective inhibition of NLRP3 inflammasome which is thought to be a major pathophysiologic component in the clinical course of patients with COVID-19. GRECCO-19 will be a prospective, randomized, open-labeled, controlled study to assess the effects of colchicine in COVID-19 complications prevention.
Methods: Patients with laboratory confirmed SARS-CoV-2 infection (under RT PCR) and clinical picture that involves temperature >37.5 oC and at least two out of the: i. sustained coughing, ii. sustained throat pain, iii. Anosmia and/or ageusia, iv. fatigue/tiredness, v. PaO2<95 mmHg will be included. Patients will be randomised (1:1) in colchicine or control group.
Results: Trial results will be disseminated through peer-reviewed publications and conference presentations.
Conclusion: GRECCO-19 trial aims to identify whether colchicine may positively intervene in the clinical course of COVID-19. (ClinicalTrials.gov Identifier: NCT04326790).
Keywords: COVID; CRP; Cardiac; Complications; Troponin.
Copyright © 2020 Hellenic Society of Cardiology. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Conflict of interest No conflict of interest exists.
Similar articles
-
Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019: The GRECCO-19 Randomized Clinical Trial.JAMA Netw Open. 2020 Jun 1;3(6):e2013136. doi: 10.1001/jamanetworkopen.2020.13136. JAMA Netw Open. 2020. PMID: 32579195 Free PMC article. Clinical Trial.
-
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9. Trials. 2020. PMID: 33115543 Free PMC article.
-
Long, relapsing, and atypical symptomatic course of COVID-19 in a B-cell-depleted patient after rituximab.Semin Arthritis Rheum. 2020 Oct;50(5):1087-1088. doi: 10.1016/j.semarthrit.2020.06.013. Epub 2020 Jun 30. Semin Arthritis Rheum. 2020. PMID: 32916559 Free PMC article. No abstract available.
-
Cardiac Troponin for Assessment of Myocardial Injury in COVID-19: JACC Review Topic of the Week.J Am Coll Cardiol. 2020 Sep 8;76(10):1244-1258. doi: 10.1016/j.jacc.2020.06.068. Epub 2020 Jul 8. J Am Coll Cardiol. 2020. PMID: 32652195 Free PMC article. Review.
-
Challenges in interpreting the diagnostic performance of symptoms to predict COVID-19 status: The case of anosmia.Int Forum Allergy Rhinol. 2020 Sep;10(9):1113-1115. doi: 10.1002/alr.22650. Epub 2020 Jul 17. Int Forum Allergy Rhinol. 2020. PMID: 32588537 Free PMC article. Review. No abstract available.
Cited by
-
Current status of COVID-19 treatment: An opinion review.World J Virol. 2020 Sep 25;9(3):27-37. doi: 10.5501/wjv.v9.i3.27. World J Virol. 2020. PMID: 33024717 Free PMC article. Review.
-
An overview on the treatments and prevention against COVID-19.Virol J. 2023 Feb 8;20(1):23. doi: 10.1186/s12985-023-01973-9. Virol J. 2023. PMID: 36755327 Free PMC article. Review.
-
Immune Profiling of COVID-19 in Correlation with SARS and MERS.Viruses. 2022 Jan 17;14(1):164. doi: 10.3390/v14010164. Viruses. 2022. PMID: 35062368 Free PMC article. Review.
-
SARS-CoV-2: lessons from both the history of medicine and from the biological behavior of other well-known viruses.Future Microbiol. 2021 Sep;16(14):1105-1133. doi: 10.2217/fmb-2021-0064. Epub 2021 Sep 1. Future Microbiol. 2021. PMID: 34468163 Free PMC article. Review.
-
COVID-19 infection and liver injury: Clinical features, biomarkers, potential mechanisms, treatment, and management challenges.World J Clin Cases. 2021 Aug 6;9(22):6178-6200. doi: 10.12998/wjcc.v9.i22.6178. World J Clin Cases. 2021. PMID: 34434987 Free PMC article. Review.
References
-
- The 2015 ESC Guidelines on the diagnosis and management of pericardial diseases. https://www.ncbi.nlm.nih.gov/pubmed/26547486 PubMed - NCBI. - PubMed
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous